Share Price and Basic Stock Data
Last Updated: January 1, 2026, 3:35 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Family Care Hospitals Ltd operates within the Hospitals & Medical Services industry, with a current market capitalization of ₹20.5 Cr. The company’s stock price is ₹3.79. Over the past few quarters, Family Care Hospitals has shown fluctuating sales figures. In the quarter ending September 2023, sales stood at ₹12.43 Cr, while in December 2023, it recorded ₹11.40 Cr. However, a significant decline was observed in the following quarters, with sales dropping to just ₹0.03 Cr by December 2024 and further to ₹0.02 Cr by March 2025. This reflects a concerning trend that suggests operational challenges. The trailing twelve months (TTM) revenue is reported at ₹0.14 Cr, indicating a stark deviation from previous years, where sales peaked at ₹42.07 Cr in March 2022. The volatility in revenue raises questions about the sustainability of the business model and its ability to adapt to market dynamics.
Profitability and Efficiency Metrics
Profitability metrics for Family Care Hospitals exhibit significant variability, with a reported net profit of -₹6.42 Cr. This negative profit indicates ongoing financial distress, especially as the company has seen net profits decline sharply from ₹5.26 Cr in March 2023 to -₹44.15 Cr in March 2025. The operating profit margin (OPM) has also faced drastic fluctuations, reported at -6,257.14% for the quarter ending September 2025, compared to a previous OPM of 19.03% in September 2022. The company’s return on equity (ROE) is extraordinarily high at 85.5%, but this figure is misleading due to the negative net profit. The interest coverage ratio (ICR) is robust at 110.60x, indicating that the company can comfortably meet its interest obligations. However, the cash conversion cycle (CCC) at 93 days suggests inefficiencies in managing receivables and payables, which may hinder cash flow and operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Family Care Hospitals presents a mixed picture. The company reported total borrowings of ₹4.85 Cr and reserves of -₹45.86 Cr, indicating a concerning leverage situation and a negative equity base. The price-to-book value (P/BV) ratio stands at 1.44x, suggesting that the market values the company’s equity higher than its book value, albeit with caution due to the negative reserves. Financial ratios reveal a current ratio of 1.28, which is generally acceptable, but the quick ratio of 0.09 raises liquidity concerns. The company has a total debt-to-equity ratio of 0.25, which is manageable but indicates reliance on external financing. Furthermore, the return on capital employed (ROCE) is exceptionally high at 79.2%, reflecting efficiency in utilizing capital despite the overall financial distress. The enterprise value (EV) is reported at ₹22.55 Cr, which is low compared to typical sector valuations.
Shareholding Pattern and Investor Confidence
The shareholding structure of Family Care Hospitals shows that promoters hold 18.54% of the company, while the public holds a substantial 81.37%. The presence of institutional investors is minimal, with foreign institutional investors (FIIs) holding 0.00% and domestic institutional investors (DIIs) at 0.09%. The number of shareholders has fluctuated, with a reported 47,432 shareholders as of September 2025. The low promoter stake may raise concerns regarding management commitment, while high public ownership reflects a broad base of retail investors. The minimal institutional investments suggest a lack of confidence from larger investors, potentially due to the company’s inconsistent financial performance. The shareholding pattern indicates that investor confidence may be waning as reflected in the declining stock price and ongoing financial struggles.
Outlook, Risks, and Final Insight
Looking ahead, Family Care Hospitals faces significant challenges that could affect its operational viability. The sharp decline in sales and profitability raises concerns about its ability to sustain operations without a strategic turnaround. Risks include high operational expenses leading to negative profit margins and potential liquidity issues stemming from a high cash conversion cycle. However, a strong interest coverage ratio indicates the company can manage its debt obligations in the short term. On the upside, if the company can stabilize its revenue streams and manage costs effectively, there is potential for recovery. The high ROE and ROCE suggest that, if operational efficiency is improved, the company could return to profitability. Stakeholders must closely monitor the company’s strategies to address these pressing financial challenges while capitalizing on any opportunities for growth in the healthcare sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 50.2 Cr. | 150 | 187/120 | 10.2 | 117 | 2.34 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 25.3 Cr. | 24.1 | 35.5/15.5 | 24.3 | 0.00 % | 13.7 % | 17.7 % | 10.0 | |
| Gian Lifecare Ltd | 9.09 Cr. | 8.79 | 20.8/7.08 | 101 | 19.1 | 0.00 % | 3.00 % | 0.81 % | 10.0 |
| Fortis Malar Hospitals Ltd | 112 Cr. | 59.5 | 98.7/55.2 | 24.7 | 18.3 | 0.00 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 20.9 Cr. | 3.86 | 6.94/3.40 | 1.51 | 0.00 % | 79.2 % | 85.5 % | 10.0 | |
| Industry Average | 26,077.71 Cr | 692.72 | 93.31 | 93.18 | 0.32% | 15.48% | 14.81% | 9.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.35 | 11.02 | 13.68 | 11.93 | 12.43 | 11.40 | 4.24 | 3.97 | 3.88 | 0.03 | 0.02 | 0.02 | 0.07 |
| Expenses | 9.19 | 9.05 | 11.48 | 9.66 | 10.42 | 9.91 | 3.27 | 3.74 | -27.09 | 1.78 | 1.06 | 0.40 | 4.45 |
| Operating Profit | 2.16 | 1.97 | 2.20 | 2.27 | 2.01 | 1.49 | 0.97 | 0.23 | 30.97 | -1.75 | -1.04 | -0.38 | -4.38 |
| OPM % | 19.03% | 17.88% | 16.08% | 19.03% | 16.17% | 13.07% | 22.88% | 5.79% | 798.20% | -5,833.33% | -5,200.00% | -1,900.00% | -6,257.14% |
| Other Income | 0.28 | 0.14 | 0.33 | 0.27 | 0.26 | 0.57 | 2.08 | 0.48 | -73.97 | 0.00 | 2.03 | 0.00 | 0.10 |
| Interest | 0.11 | 0.14 | 0.12 | 0.29 | 0.15 | 0.09 | 0.09 | 0.09 | 0.06 | 0.07 | 0.07 | 0.08 | 0.10 |
| Depreciation | 0.35 | 0.36 | 0.33 | 0.36 | 0.36 | 0.36 | 0.34 | 0.32 | 0.28 | 0.28 | 0.25 | 0.23 | 0.23 |
| Profit before tax | 1.98 | 1.61 | 2.08 | 1.89 | 1.76 | 1.61 | 2.62 | 0.30 | -43.34 | -2.10 | 0.67 | -0.69 | -4.61 |
| Tax % | 25.76% | 26.09% | 37.02% | 29.10% | 28.41% | 30.43% | -227.48% | 26.67% | -0.18% | 0.00% | -47.76% | 0.00% | 0.00% |
| Net Profit | 1.46 | 1.19 | 1.30 | 1.34 | 1.26 | 1.12 | 8.58 | 0.23 | -43.27 | -2.10 | 0.99 | -0.70 | -4.61 |
| EPS in Rs | 0.20 | 0.16 | 0.24 | 0.25 | 0.23 | 0.21 | 1.59 | 0.04 | -8.01 | -0.39 | 0.18 | -0.13 | -0.85 |
Last Updated: December 27, 2025, 12:37 am
Below is a detailed analysis of the quarterly data for Family Care Hospitals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.07 Cr.. The value appears strong and on an upward trend. It has increased from 0.02 Cr. (Jun 2025) to 0.07 Cr., marking an increase of 0.05 Cr..
- For Expenses, as of Sep 2025, the value is 4.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.40 Cr. (Jun 2025) to 4.45 Cr., marking an increase of 4.05 Cr..
- For Operating Profit, as of Sep 2025, the value is -4.38 Cr.. The value appears to be declining and may need further review. It has decreased from -0.38 Cr. (Jun 2025) to -4.38 Cr., marking a decrease of 4.00 Cr..
- For OPM %, as of Sep 2025, the value is -6,257.14%. The value appears to be declining and may need further review. It has decreased from -1,900.00% (Jun 2025) to -6,257.14%, marking a decrease of 4,357.14%.
- For Other Income, as of Sep 2025, the value is 0.10 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 0.10 Cr., marking an increase of 0.10 Cr..
- For Interest, as of Sep 2025, the value is 0.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.08 Cr. (Jun 2025) to 0.10 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.23 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.23 Cr..
- For Profit before tax, as of Sep 2025, the value is -4.61 Cr.. The value appears to be declining and may need further review. It has decreased from -0.69 Cr. (Jun 2025) to -4.61 Cr., marking a decrease of 3.92 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -4.61 Cr.. The value appears to be declining and may need further review. It has decreased from -0.70 Cr. (Jun 2025) to -4.61 Cr., marking a decrease of 3.91 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.85. The value appears to be declining and may need further review. It has decreased from -0.13 (Jun 2025) to -0.85, marking a decrease of 0.72.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:45 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.01 | 0.07 | 1.07 | 1.80 | 5.19 | 14.19 | 13.25 | 35.36 | 42.07 | 42.04 | 40.01 | 7.90 | 0.14 |
| Expenses | 0.35 | 0.24 | 0.86 | 1.54 | 3.84 | 12.73 | 10.98 | 27.18 | 33.37 | 33.59 | 33.12 | -21.33 | 7.69 |
| Operating Profit | -0.34 | -0.17 | 0.21 | 0.26 | 1.35 | 1.46 | 2.27 | 8.18 | 8.70 | 8.45 | 6.89 | 29.23 | -7.55 |
| OPM % | -3,400.00% | -242.86% | 19.63% | 14.44% | 26.01% | 10.29% | 17.13% | 23.13% | 20.68% | 20.10% | 17.22% | 370.00% | -5,392.86% |
| Other Income | 0.00 | -24.63 | 0.20 | 0.19 | 0.24 | 0.04 | -0.12 | -0.28 | 0.30 | 0.98 | 3.19 | -71.71 | 2.13 |
| Interest | 0.00 | 0.00 | 0.01 | 0.01 | 0.12 | 0.51 | 0.84 | 0.83 | 0.50 | 0.60 | 0.53 | 0.86 | 0.32 |
| Depreciation | 0.00 | 0.03 | 0.38 | 0.25 | 0.39 | 0.94 | 1.28 | 1.42 | 1.44 | 1.41 | 1.42 | 1.13 | 0.99 |
| Profit before tax | -0.34 | -24.83 | 0.02 | 0.19 | 1.08 | 0.05 | 0.03 | 5.65 | 7.06 | 7.42 | 8.13 | -44.47 | -6.73 |
| Tax % | 0.00% | 0.00% | 0.00% | 21.05% | 20.37% | 60.00% | 33.33% | 27.96% | 26.35% | 29.11% | -54.24% | -0.72% | |
| Net Profit | -0.34 | -24.83 | 0.02 | 0.16 | 0.86 | 0.02 | 0.03 | 4.07 | 5.20 | 5.26 | 12.55 | -44.15 | -6.42 |
| EPS in Rs | -3.41 | 0.00 | 0.02 | 0.12 | 0.00 | 0.00 | 0.56 | 0.71 | 0.97 | 2.32 | -8.17 | -1.19 | |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.17% | 5.13% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -7202.94% | 100.08% | 700.00% | 437.50% | -97.67% | 50.00% | 13466.67% | 27.76% | 1.15% | 138.59% | -451.79% |
| Change in YoY Net Profit Growth (%) | 0.00% | 7303.02% | 599.92% | -262.50% | -535.17% | 147.67% | 13416.67% | -13438.90% | -26.61% | 137.44% | -590.39% |
Family Care Hospitals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 60% |
| 5 Years: | -10% |
| 3 Years: | -43% |
| TTM: | -88% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 79% |
| 5 Years: | 186% |
| 3 Years: | 80% |
| TTM: | 164% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -8% |
| 3 Years: | -43% |
| 1 Year: | -43% |
| Return on Equity | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | 42% |
| 3 Years: | 41% |
| Last Year: | 85% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: December 4, 2025, 2:51 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.00 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 54.01 | 54.01 | 54.01 | 54.01 |
| Reserves | -3.36 | -28.18 | -28.16 | -28.01 | -27.15 | -27.13 | -27.09 | -23.03 | -17.86 | -8.21 | 4.36 | -40.56 | -45.86 |
| Borrowings | 0.41 | 0.56 | 0.56 | 0.10 | 0.28 | 5.60 | 9.53 | 5.50 | 4.26 | 4.32 | 3.65 | 3.39 | 4.85 |
| Other Liabilities | 0.01 | 0.04 | 0.08 | 1.31 | 4.66 | 3.22 | 2.59 | 5.81 | 21.34 | 24.46 | 7.94 | 29.26 | 32.50 |
| Total Liabilities | 0.06 | 4.52 | 4.58 | 5.50 | 9.89 | 13.79 | 17.13 | 20.38 | 39.84 | 74.58 | 69.96 | 46.10 | 45.50 |
| Fixed Assets | 0.00 | 1.74 | 1.84 | 2.44 | 7.24 | 8.61 | 9.52 | 8.01 | 6.82 | 6.93 | 5.95 | 4.00 | 3.54 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.60 | 0.86 | 0.06 | 0.04 | 0.09 | 0.09 | 0.09 | 0.06 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.06 | 2.78 | 2.74 | 2.46 | 1.79 | 5.12 | 7.57 | 12.28 | 32.93 | 67.56 | 63.95 | 42.10 | 41.96 |
| Total Assets | 0.06 | 4.52 | 4.58 | 5.50 | 9.89 | 13.79 | 17.13 | 20.38 | 39.84 | 74.58 | 69.96 | 46.10 | 45.50 |
Below is a detailed analysis of the balance sheet data for Family Care Hospitals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 54.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 54.01 Cr..
- For Reserves, as of Sep 2025, the value is -45.86 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -40.56 Cr. (Mar 2025) to -45.86 Cr., marking a decline of 5.30 Cr..
- For Borrowings, as of Sep 2025, the value is 4.85 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 3.39 Cr. (Mar 2025) to 4.85 Cr., marking an increase of 1.46 Cr..
- For Other Liabilities, as of Sep 2025, the value is 32.50 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.26 Cr. (Mar 2025) to 32.50 Cr., marking an increase of 3.24 Cr..
- For Total Liabilities, as of Sep 2025, the value is 45.50 Cr.. The value appears to be improving (decreasing). It has decreased from 46.10 Cr. (Mar 2025) to 45.50 Cr., marking a decrease of 0.60 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3.54 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 3.54 Cr., marking a decrease of 0.46 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 41.96 Cr.. The value appears to be declining and may need further review. It has decreased from 42.10 Cr. (Mar 2025) to 41.96 Cr., marking a decrease of 0.14 Cr..
- For Total Assets, as of Sep 2025, the value is 45.50 Cr.. The value appears to be declining and may need further review. It has decreased from 46.10 Cr. (Mar 2025) to 45.50 Cr., marking a decrease of 0.60 Cr..
However, the Borrowings (4.85 Cr.) are higher than the Reserves (-45.86 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.75 | -0.73 | -0.35 | 0.16 | 1.07 | -4.14 | -7.26 | 2.68 | 4.44 | 4.13 | 3.24 | 25.84 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 65 | 113 | 93 | 186 | 252 | 310 | 93 |
| Inventory Days | 149 | 29 | 4 | 6 | 16 | |||||||
| Days Payable | 977 | 212 | 382 | 387 | 126 | |||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 65 | -715 | -89 | -193 | -129 | 201 | 93 |
| Working Capital Days | -14,600 | -2,920 | -160 | -272 | -312 | -146 | -16 | 55 | 100 | 149 | 255 | 402 |
| ROCE % | -2,267% | -4% | 1% | 5% | 25% | 7% | 8% | 47% | 46% | 23% | 15% | 77% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -8.17 | 2.32 | 0.16 | 1.62 | 1.27 |
| Diluted EPS (Rs.) | -8.17 | 2.32 | 0.16 | 1.62 | 1.27 |
| Cash EPS (Rs.) | -7.96 | 2.59 | 1.23 | 2.07 | 1.71 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 2.49 | 10.81 | 8.48 | 4.44 | 2.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 2.49 | 10.81 | 8.48 | 4.44 | 2.83 |
| Dividend / Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 |
| Revenue From Operations / Share (Rs.) | 1.46 | 7.41 | 8.76 | 13.10 | 11.01 |
| PBDIT / Share (Rs.) | 5.84 | 1.84 | 1.72 | 2.78 | 2.45 |
| PBIT / Share (Rs.) | 5.63 | 1.58 | 1.46 | 2.33 | 2.00 |
| PBT / Share (Rs.) | -8.23 | 1.50 | 1.37 | 2.20 | 1.76 |
| Net Profit / Share (Rs.) | -8.17 | 2.32 | 0.97 | 1.62 | 1.27 |
| PBDIT Margin (%) | 399.32 | 24.83 | 19.69 | 21.22 | 22.21 |
| PBIT Margin (%) | 385.07 | 21.28 | 16.71 | 17.80 | 18.20 |
| PBT Margin (%) | -562.54 | 20.32 | 15.68 | 16.79 | 15.98 |
| Net Profit Margin (%) | -558.47 | 31.36 | 11.11 | 12.35 | 11.52 |
| Return on Networth / Equity (%) | -327.98 | 21.49 | 11.47 | 36.50 | 44.90 |
| Return on Capital Employeed (%) | 219.07 | 14.21 | 14.74 | 37.71 | 42.77 |
| Return On Assets (%) | -95.77 | 17.93 | 7.07 | 13.05 | 19.99 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.04 | 0.14 | 0.47 |
| Total Debt / Equity (X) | 0.25 | 0.06 | 0.09 | 0.29 | 0.60 |
| Asset Turnover Ratio (%) | 0.13 | 0.55 | 0.82 | 1.40 | 1.89 |
| Current Ratio (X) | 1.28 | 5.51 | 2.83 | 1.59 | 2.08 |
| Quick Ratio (X) | 0.09 | 5.45 | 2.82 | 1.58 | 2.02 |
| Inventory Turnover Ratio (X) | 0.40 | 89.27 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 110.60 | 25.90 | 19.15 | 20.92 | 10.01 |
| Interest Coverage Ratio (Post Tax) (X) | 107.78 | 33.71 | 11.81 | 13.18 | 6.19 |
| Enterprise Value (Cr.) | 22.55 | 23.96 | 45.75 | 67.13 | 54.81 |
| EV / Net Operating Revenue (X) | 2.85 | 0.59 | 0.96 | 1.60 | 1.55 |
| EV / EBITDA (X) | 0.71 | 2.41 | 4.91 | 7.52 | 6.98 |
| MarketCap / Net Operating Revenue (X) | 2.45 | 0.94 | 1.28 | 1.50 | 1.41 |
| Price / BV (X) | 1.44 | 0.64 | 1.33 | 4.43 | 5.48 |
| Price / Net Operating Revenue (X) | 2.45 | 0.94 | 1.28 | 1.50 | 1.41 |
| EarningsYield | -2.28 | 0.33 | 0.08 | 0.08 | 0.08 |
After reviewing the key financial ratios for Family Care Hospitals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -8.17. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 24) to -8.17, marking a decrease of 10.49.
- For Diluted EPS (Rs.), as of Mar 25, the value is -8.17. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 24) to -8.17, marking a decrease of 10.49.
- For Cash EPS (Rs.), as of Mar 25, the value is -7.96. This value is below the healthy minimum of 3. It has decreased from 2.59 (Mar 24) to -7.96, marking a decrease of 10.55.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2.49. It has decreased from 10.81 (Mar 24) to 2.49, marking a decrease of 8.32.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2.49. It has decreased from 10.81 (Mar 24) to 2.49, marking a decrease of 8.32.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.46. It has decreased from 7.41 (Mar 24) to 1.46, marking a decrease of 5.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.84. This value is within the healthy range. It has increased from 1.84 (Mar 24) to 5.84, marking an increase of 4.00.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.63. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 5.63, marking an increase of 4.05.
- For PBT / Share (Rs.), as of Mar 25, the value is -8.23. This value is below the healthy minimum of 0. It has decreased from 1.50 (Mar 24) to -8.23, marking a decrease of 9.73.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -8.17. This value is below the healthy minimum of 2. It has decreased from 2.32 (Mar 24) to -8.17, marking a decrease of 10.49.
- For PBDIT Margin (%), as of Mar 25, the value is 399.32. This value is within the healthy range. It has increased from 24.83 (Mar 24) to 399.32, marking an increase of 374.49.
- For PBIT Margin (%), as of Mar 25, the value is 385.07. This value exceeds the healthy maximum of 20. It has increased from 21.28 (Mar 24) to 385.07, marking an increase of 363.79.
- For PBT Margin (%), as of Mar 25, the value is -562.54. This value is below the healthy minimum of 10. It has decreased from 20.32 (Mar 24) to -562.54, marking a decrease of 582.86.
- For Net Profit Margin (%), as of Mar 25, the value is -558.47. This value is below the healthy minimum of 5. It has decreased from 31.36 (Mar 24) to -558.47, marking a decrease of 589.83.
- For Return on Networth / Equity (%), as of Mar 25, the value is -327.98. This value is below the healthy minimum of 15. It has decreased from 21.49 (Mar 24) to -327.98, marking a decrease of 349.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is 219.07. This value is within the healthy range. It has increased from 14.21 (Mar 24) to 219.07, marking an increase of 204.86.
- For Return On Assets (%), as of Mar 25, the value is -95.77. This value is below the healthy minimum of 5. It has decreased from 17.93 (Mar 24) to -95.77, marking a decrease of 113.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has increased from 0.06 (Mar 24) to 0.25, marking an increase of 0.19.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.13. It has decreased from 0.55 (Mar 24) to 0.13, marking a decrease of 0.42.
- For Current Ratio (X), as of Mar 25, the value is 1.28. This value is below the healthy minimum of 1.5. It has decreased from 5.51 (Mar 24) to 1.28, marking a decrease of 4.23.
- For Quick Ratio (X), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 1. It has decreased from 5.45 (Mar 24) to 0.09, marking a decrease of 5.36.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 4. It has decreased from 89.27 (Mar 24) to 0.40, marking a decrease of 88.87.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 110.60. This value is within the healthy range. It has increased from 25.90 (Mar 24) to 110.60, marking an increase of 84.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 107.78. This value is within the healthy range. It has increased from 33.71 (Mar 24) to 107.78, marking an increase of 74.07.
- For Enterprise Value (Cr.), as of Mar 25, the value is 22.55. It has decreased from 23.96 (Mar 24) to 22.55, marking a decrease of 1.41.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.85. This value is within the healthy range. It has increased from 0.59 (Mar 24) to 2.85, marking an increase of 2.26.
- For EV / EBITDA (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 5. It has decreased from 2.41 (Mar 24) to 0.71, marking a decrease of 1.70.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.45. This value is within the healthy range. It has increased from 0.94 (Mar 24) to 2.45, marking an increase of 1.51.
- For Price / BV (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from 0.64 (Mar 24) to 1.44, marking an increase of 0.80.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.45. This value is within the healthy range. It has increased from 0.94 (Mar 24) to 2.45, marking an increase of 1.51.
- For EarningsYield, as of Mar 25, the value is -2.28. This value is below the healthy minimum of 5. It has decreased from 0.33 (Mar 24) to -2.28, marking a decrease of 2.61.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Family Care Hospitals Ltd:
- Net Profit Margin: -558.47%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 219.07% (Industry Average ROCE: 15.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -327.98% (Industry Average ROE: 14.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 107.78
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.09
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 93.31)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -558.47%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | A-357, Road No.26, Wagle Industrial Estate, Thane Maharashtra 400604 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Suchit Raghunath Modshing | Whole Time Director |
| Mr. Dhanajay Parikh | Ind. Non-Executive Director |
| Ms. Lucy Massey | Non Exe.Non Ind.Director |
| Mr. Sanjeev Seth | Ind. Non-Executive Director |
| Mrs. Archana Chirawawala | Ind. Non-Executive Director |
| Mr. Nitesh Singh | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Family Care Hospitals Ltd?
Family Care Hospitals Ltd's intrinsic value (as of 01 January 2026) is ₹15.80 which is 309.33% higher the current market price of ₹3.86, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹20.9 Cr. market cap, FY2025-2026 high/low of ₹6.94/3.40, reserves of ₹-45.86 Cr, and liabilities of ₹45.50 Cr.
What is the Market Cap of Family Care Hospitals Ltd?
The Market Cap of Family Care Hospitals Ltd is 20.9 Cr..
What is the current Stock Price of Family Care Hospitals Ltd as on 01 January 2026?
The current stock price of Family Care Hospitals Ltd as on 01 January 2026 is ₹3.86.
What is the High / Low of Family Care Hospitals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Family Care Hospitals Ltd stocks is ₹6.94/3.40.
What is the Stock P/E of Family Care Hospitals Ltd?
The Stock P/E of Family Care Hospitals Ltd is .
What is the Book Value of Family Care Hospitals Ltd?
The Book Value of Family Care Hospitals Ltd is 1.51.
What is the Dividend Yield of Family Care Hospitals Ltd?
The Dividend Yield of Family Care Hospitals Ltd is 0.00 %.
What is the ROCE of Family Care Hospitals Ltd?
The ROCE of Family Care Hospitals Ltd is 79.2 %.
What is the ROE of Family Care Hospitals Ltd?
The ROE of Family Care Hospitals Ltd is 85.5 %.
What is the Face Value of Family Care Hospitals Ltd?
The Face Value of Family Care Hospitals Ltd is 10.0.